Stock CDIX CARDIFF LEXINGTON CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Cardiff Lexington Corporation

Equities

CDIX

US14146R6018

Healthcare Facilities & Services

Market Closed - OTC Markets
Other stock markets
 12:12:16 2024-04-26 pm EDT 		5-day change 1st Jan Change
7.5 USD +130.77% Intraday chart for Cardiff Lexington Corporation +15.38% -50.13%
Mar. 28 Earnings Flash (CDIX) CARDIFF LEXINGTON CORPORATION Posts Q4 Revenue $2.4M MT
Mar. 27 Cardiff Lexington Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 - - 0.0957 0.2325 0.2561 0.361
Enterprise Value (EV) 1 - - 3.912 2.741 4.088 5.98
P/E ratio - - - - - 0.1 x
Yield - - - - - -
Capitalization / Revenue - - 0.03 x 0.02 x 0.02 x 0.03 x
EV / Revenue - - 1.13 x 0.27 x 0.34 x 0.5 x
EV / EBITDA - - -2.2 x 1.65 x 1.07 x 1.15 x
EV / FCF - - -7.16 x -0.28 x -0.95 x -1.92 x
FCF Yield - - -14% -357% -105% -52%
Price to Book - - - - -0.01 x -0 x
Nbr of stocks (in thousands) - - 0.07 2.21 3.1 24
Reference price 2 13,493 833,077 1,429 105.3 82.71 15.04
Announcement Date 4/16/19 4/14/20 3/31/21 10/21/22 6/6/23 3/27/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 2.374 4.541 3.453 10.01 12 11.85
EBITDA 1 -2.488 -1.248 -1.781 1.661 3.807 5.216
EBIT 1 -2.568 -1.316 -1.804 1.626 3.784 5.195
Operating Margin -108.17% -28.98% -52.25% 16.25% 31.54% 43.83%
Earnings before Tax (EBT) 1 -6.265 -6.073 -2.974 -1.429 -5.47 3.115
Net income 1 -6.265 -6.364 -2.905 -0.4097 -5.43 3.028
Net margin -263.92% -140.13% -84.13% -4.09% -45.25% 25.55%
EPS - - - - - 155.7
Free Cash Flow 1 -0.2899 2.379 -0.5462 -9.792 -4.306 -3.109
FCF margin -12.21% 52.39% -15.82% -97.83% -35.89% -26.23%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/16/19 4/14/20 3/31/21 10/21/22 6/6/23 3/27/24
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 2.89 2.38 3.82 2.51 3.83 5.62
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -1.163 x -1.903 x -2.142 x 1.51 x 1.007 x 1.077 x
Free Cash Flow 1 -0.29 2.38 -0.55 -9.79 -4.31 -3.11
ROE (net income / shareholders' equity) 151% 113% 42.4% 46.9% -156% 63.7%
ROA (Net income/ Total Assets) -68.9% -19.1% -22.9% 12.6% 16.5% 19%
Assets 1 9.096 33.39 12.68 -3.243 -32.89 15.9
Book Value Per Share - - - - -7,485 -3,168
Cash Flow per Share - - - - 21.60 36.00
Capex 1 0.85 - - 0 - -
Capex / Sales 35.89% - - 0.03% - -
Announcement Date 4/16/19 4/14/20 3/31/21 10/21/22 6/6/23 3/27/24
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
CARDIFF LEXINGTON CORPORATION Stock Cardiff Lexington Corporation
-50.13% 306M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
DAVITA INC. Stock DaVita Inc.
+27.44% 11.71B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. CDIX Stock
  4. Financials Cardiff Lexington Corporation